HK Stock Market Move | TIANYU SEMI (02658) rises by more than 7%, demand for AI chips expected to remain strong, company's new production base in Dongguan Eco Park has been put into use.
Tianyu Semiconductor (02658) rose over 7%, as of the time of writing, it rose 7.34% to HK$47.66, with a trading volume of HK$5.415 million.
TIANYU SEMI (02658) rose more than 7%, rising 7.34% to HK$47.66 as of press time, with a transaction amount of 5.415 million Hong Kong dollars.
On the news front, on April 16, TSMC released its first quarter 2026 performance and held an analyst meeting. TSMC stated that the demand for artificial intelligence is extremely strong, and chip demand will continue to remain strong. Huatai believes that since the second half of 2025, the rapid rise of AI chat services represented by BeanChat and the application of AgentAI represented by "Xiaolongxia" have been driving the rapid growth of domestic computing power demand for inference.
Previously, TIANYU SEMI released its 2025 performance, with the company achieving operating income of 709 million yuan in 2025, a year-on-year increase of 36.49%. The announcement stated that the increase in revenue was mainly due to the volume-driven sales strategy driving a significant increase in sales (especially 6-inch and 8-inch silicon carbide epitaxial wafer sales), offset in part by the average selling price decline of silicon carbide epitaxial wafers, and the increase in revenue generated by the provision of foundry services. In terms of production capacity, the company's new production base in Dongguan Eco-Park has been put into use, making the company one of the major manufacturers in China with large-scale production capacity for both 6-inch and 8-inch epitaxial wafers.
Related Articles

New stock news | Fylaland submits application to Hong Kong Stock Exchange for China's largest smart pool equipment supplier.

New stock news | Capital (601136.SH) submits a second application to the Hong Kong Stock Exchange, with total revenue exceeding 3.6 billion yuan in 2025.

Jiangsu Kanion Pharmaceutical (600557.SH) has received the approval notice for the clinical trial of Qingcan Tongluo Granules.
New stock news | Fylaland submits application to Hong Kong Stock Exchange for China's largest smart pool equipment supplier.

New stock news | Capital (601136.SH) submits a second application to the Hong Kong Stock Exchange, with total revenue exceeding 3.6 billion yuan in 2025.

Jiangsu Kanion Pharmaceutical (600557.SH) has received the approval notice for the clinical trial of Qingcan Tongluo Granules.

RECOMMEND

Hong Kong Hard‑Tech Companies Enhance Canton Fair Presence As Veterans And Newcomers Expand International Networks
17/04/2026

Thousand‑Fold Oversubscription In Hong Kong IPOs Signals Multiple Market Shifts
17/04/2026

Rising Compute Costs Drive Industry Price Increases As Institutions Expect Internet Firms To Outperform In Q1
17/04/2026


